The automated breast ultrasound systems market is estimated to capture a valuation of USD 1.95 billion in 2023 and is projected to reach USD 7.23 billion by 2033. The market is estimated to secure a CAGR of 14% by 2033.
| Attribute | Details |
|---|---|
| Market CAGR (2023 to 2033) | 14% |
| Market Valuation (2023) | USD 1.95 billion |
| Market Valuation (2033) | USD 7.23 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising necessity of accurate diagnosis of breast lesions, especially during the early stages of cancer, and the lack of skilled radiologists to operate the conventional ultrasound system is promoting major manufacturing companies towards developing modern, precise, and automated diagnosis systems.
Implementing high-frequency sound waves to map the entire breast and create 3D monochromatic images of tissues and breast structures has fueled the market demand. The surging incidence of breast cancer is also attributed to an increasing preference towards a sedentary lifestyle and obesity.
According to World Health Organization, more than 50% of women in Latin America are suffering from obesity. Several leading organizations invest in research and development to offer novel technologies for timely diagnosis.
For instance, GE Healthcare launched a new automated breast ultrasound system named "Invenia" in the United States in October 2018. The system's main function is to identify the presence of mammographically occult cancer, especially in women with dense tissues.
Integrating an automated breast ultrasound system with other digital cancer screening operations and procedures yields a more accurate prognosis and promotes ABUS's rapid adoption in diagnostics laboratories.
According to a report by the National Library of Medicine, integrating mammography with an automated breast ultrasound system increased the system's sensitivity to 99.1%. The combination drastically improves the cancer detection rate among dense-breasted women and reduces the interpretation time.
Studies highlighting the benefits of automated breast ultrasound systems create attractive opportunities for the market in the coming years.
A radiologist with expertise in ABUS is required to correctly interpret the volumetric 3D images and identify the region of the breast lesion. The lack of skilled radiologists and the increased cost of standardized training hamper the market growth.
Lack of awareness in emerging economies regarding breast cancer and underdeveloped healthcare infrastructure in underdeveloped countries are also hindering the market growth.
According to Winship Cancer Institute, breast ultrasound is more susceptible to producing false positives than mammography. The breast ultrasound system is also not equipped to indicate whether the tumor is benign or cancerous. The inability to display calcification among women above 45 years is a major concern among the market players.
Principal Consultant
As per Future Market Insights (FMI), the global market captured a valuation of USD 1.01 billion in 2018 and USD 1.71 billion in 2022.
According to the report by Future Market Insights, the demand for automated breast ultrasound systems [ABUS] has been increasing significantly with the rising prevalence of breast cancer across the globe.
According to a report published by the American Society of Clinical Oncology, In India, 162,468 new breast cancer cases were reported in 2018. Also, breast cancer accounted for 11% of all cancer deaths in India, according to the study.
Major progress has been witnessed with the 3D automated breast ultrasound systems, especially when complemented with full-field digital screening mammography (FFDSM), owing to relatively higher accuracy in invasive breast cancer diagnosis and faster recall features.
A slight drop in demand was observed in the initial half of 2020, attributed to the imposition of stringent lockdowns amid the COVID-19 pandemic. The pandemic compelled doctors to limit breast ultrasound procedures to urgent and critical patients only.
The steps were taken to break the transmission chain of the virus. The skilled professionals were allocated towards tending the COVID patients, thus restricting the market demand. However, strong recovery is underway as breast cancer cases are surging globally.
In the future, the market is poised to grow significantly, as the majority of diagnostics centers are switching towards automated breast ultrasound systems from radiology and MRI techniques. India and the United Kingdom are likely to yield highly opportunistic prospects, contributing towards the market's overall expansion.
Hospitals and related services are anticipated to generate higher demand throughout the forecast period. A growing pool of patients and faster accessibility of medical tools and equipment, and the presence of skilled personnel is estimated to elevate the demand in Hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market in the United States is anticipated to grow exponentially during the forecast period due to the growing prevalence of breast cancer across the country.
According to the American Society of Cancer, in 2021, nearly 281,550 new breast cancer cases were detected in women, with 43,600 dying of breast cancer.
The rising incidence of breast cancer is estimated to fuel the demand for advanced breast imaging technologies and promote effective treatments. Increasing government campaigns to spread awareness and educate women about breast cancer and the importance of screening is estimated to boost the ABUS market in the United States.
Awareness initiatives undertaken by various foundations in the United States include National Breast Cancer Awareness (NBCA) month by the American Society of Cancer, awareness campaigns run by the National Breast Cancer Foundation, and the Susan Komen Foundation. These positively influence the demand for automated breast ultrasound systems to screen breast cancer in dense breast tissue.
Presence of developed healthcare infrastructure and increased consumer spending on healthcare is a key automated breast ultrasound systems market in the United Kingdom. According to Cancer Research United Kingdom, in 2017, approximately 54,700 new breast cancer cases were detected in women. Growing instances of cancer is estimated to boost the demand for advanced non-invasive breast imaging technologies.
Increasing mortality rates due to breast cancer is estimated to fuel the demand for developing modern cancer screening technology. The rising prevalence of obesity and growing alcohol abuse propels breast cancer cases, accelerating product demand. With ABUS's improved efficiency and effectiveness in mammography systems, steady market growth is expected during the forecast period.
According to the German Center for Cancer Registry Data, breast cancer is the most common form of cancer in Germany, with approximately 67,000 new cases of breast cancer observed in women in 2017.
The presence of market leaders like Siemens and modern healthcare systems boost the ABUS market in Germany during the forecast period. High per capita income and increased awareness regarding breast cancer screening positively influence the demand for automated breast ultrasound systems.
Market players are working towards optimizing the automated breast ultrasound market in compliance with Germany's strict government regulations and policies.
Rapid urbanization and the increasing spending power of consumers in Saudi Arabia offer novel market growth opportunities. Establishing state-of-the-art cancer diagnostics centers like King Abdullah Medical City-Oncology Center is estimated to positively influence the demand for the automated breast ultrasound system market.
Increasing government and private funding and favorable insurance policies are estimated to boost ABUS market sales. According to Global Cancer Observatory, breast cancer comprised nearly 14.2% of total new cancer incidences in Saudi Arabia in 2020.
The increasing prevalence of breast cancer is estimated to promote the research and development of ABUS technology, providing further momentum to market growth.
Market growth in India is expected to happen at a faster rate. Breast Cancer India has reported that in 2018, about 27.7% of all new cancer cases diagnosed in women were breast cancers.
The rising population and increasing per capita income are estimated to provide a favorable climate for the automated breast ultrasound systems market. The report also states that in 2018, India had the second higher breast cancer mortality rate, with 87,090 women losing their lives to breast cancer.
These numbers indicate huge market penetration potential in India. Growing government initiatives to spread awareness regarding breast cancer among women and campaigns to reduce the mortality rate are estimated to be key factors driving growth in the market.
Key market players in the automated breast ultrasound system market are focusing on installing ABUS in hospitals and diagnostics centers to expand their global footprint. They are also working towards developing the accuracy of automated breast ultrasound systems for faster cancer screening assessment and getting government approval for their products.
Key players are investing heavily in research and development activities to develop essential and improved products. These players are adopting various market methodologies such as mergers, acquisitions, product launches, collaborations, and partnerships. They are distributing their products with local and international suppliers to reach relevant audiences to increase sales volume.
Other Essential Players in the Global Market are:
Recent Developments in the Global Market
Automated breast ultrasound system named “AWBUS” made by SonoCiné is capable of providing repeated scans of the whole breast with the same consistency and accuracy necessary for the accurate detection of cancer.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | End Use Application, Region |
| Key Companies Profiled | GE Healthcare; Hitachi Ltd; SonoCine Inc; Philips Healthcare; Siemens Healthineers; Supersonic Imagine; Toshiba Corporation; QT Ultrasound LLC; Adaltis S.r.l.; Volpara Health Technologies; Delphinus Medical Technologies, Inc; General Electric Company; Hologic, Inc; Telemed Systems, Inc |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 1.9 billion in 2023.
GE Healthcare, Hitachi Ltd., and SonoCine Inc. are key market players.
The market will reach USD 7.2 billion by 2033.
Rising incidence of breast cancer will drive the market prospects.
Hospitals segment is likely to remain preferred through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Automated Breast Ultrasound System 5.2. Automated Breast Volume Scanner 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Healthcare Providers 6.2. Diagnostic Imaging Centres 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. Asia Pacific 7.5. MEA 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Key Countries Market Analysis 14. Market Structure Analysis 15. Competition Analysis 15.1. General Electric Company (GE Healthcare) 15.2. Siemens Healthineers AG 15.3. Koninklijke Philips N.V. 15.4. Hitachi, Ltd. 15.5. SonoCiné Inc. 15.6. Telemed Medical Systems 15.7. Hologic, Inc. 15.8. Fujifilm Holdings Corporation 15.9. Canon Medical Systems Corporation 15.10. Mindray Medical International Limited 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Automated Breast Ultrasound Systems Market
